Literature Review: Efektivitas, Keamanan, dan Biaya Terapi Imidafenacin untuk Pasien Overactive Bladder
Imidafenacin is a new antimuscarinic agent in Indonesia that was recently approved in 2019 to treat overactive bladder (OAB) symptoms, including urinary incontinence, urinary frequency, and urinary urgency. As a new OAB medication in the Indonesian commercial market, a comprehensive review on the ef...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Politeknik Kesehatan Tanjung Karang
2020-12-01
|
| Series: | Jurnal Kesehatan |
| Subjects: | |
| Online Access: | https://ejurnal.poltekkes-tjk.ac.id/index.php/JK/article/view/2256 |